M2-polarized TAMs can inhibit cytotoxic T lymphocytes (CTL) [95], recruit Tregs [96], and release PGE2 and TGF-β [97] to change the TME to an immunosuppressive microenvironment [98], allowing tumor cells to escape immune surveillance (Figure 2b). This evidence concerns the gene TGFB1 and neoplasm.